Ms. Adrian Bernadette Crowe, NURSE PRACTITIONER Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 5870 Silver Hill Road, Minute Clinic Inside Cvs Store, District Heights, MD 20747 Phone: 301-736-3994 Fax: 301-967-1344 |
Bilikisu Osman, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 8839 Ritchboro Rd, District Heights, MD 20747 Phone: 301-996-4885 |
Barbra Bonsu, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 2421 Ramblewood Dr, District Heights, MD 20747 Phone: 201-397-6694 |
Dr. Kiera Elysse Leonard, DNP, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 7505 Mildreds Ln, District Heights, MD 20747 Phone: 301-781-6644 |
Titilayo Otunuga, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 6400 Marlboro Pike, District Heights, MD 20747 Phone: 301-736-7000 |
Ms. Nicole Haskins, RN, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 6400 Marlboro Pike, District Heights, MD 20747 Phone: 301-736-7000 Fax: 301-736-6916 |
News Archive
It has long been accepted that regular exercise can assist in helping to prevent or reduce the risk of a multitude of health problems.
A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.
Using genome sequencing and household surveillance, National Institutes of Health (NIH) scientists and their colleagues from Columbia University Medical Center and St. George's University of London have pieced together how a newly emerging type of Staphylococcus aureus bacteria has adapted to transmit more easily among humans.
Biomoda, Inc. (www.biomoda.com) and Advanced Medical Imaging and Genetics (www.amigenics.com), an innovative medical clinic specializing in prevention and early detection of disease, announced their intent to collaborate on a variety of projects to advance technology for the early detection of lung and other cancer.
Abiomed, Inc. today announced that the U.S. Food and Drug Administration (FDA) will convene an expert panel of cardiovascular surgeons and cardiologists to review the groundbreaking technologies and clinical trial data behind the AbioCor artificial heart.
› Verified 3 days ago